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The study was conducted to determine the effects of constructed recombinant 
Lactococcus lactis and bacteriocin UL4 for the protection of tilapia against 
Aeromonas hydrophila. For the constructions of recombinant L. lactis, a 250 bp 
domain 1 and 750 bp domain 4 of aerolysin produced by A. hydrophila were 
amplified by PCR and individually cloned into pNZ8048. The constructed plasmids, 
designated as pNHD1 and pNHD4, were then electrotransformed into Lactococcus 
lactis. Total RNA was then extracted and subjected to reverse transcriptase PCR. The 
agarose gel electrophoresis results showed the expected bands of pNHD1 and 
pNHD4 with 268 bp and 768 bp respectively. Subsequently, whole cell protein of 
recombinant L. lactis was extracted and separated by SDS-PAGE prior to Western 
blot analysis. The results of immunoblots using specific polyclonal antibodies 
showed that both domains 1 (~9 kDa) and 4 (~30 kDa) were successfully expressed 
in L. lactis.  
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 On the first fish trial, tilapia was injected intraperitoneally using recombinant L. 
lactis. Growth performance of tilapia with recombinant L. lactis was more profound 
and ELISA results showed a significantly higher antibody level (P<0.05) compared 
to control groups. The survival rate after challenge was more than 80 % for 
recombinant L. lactis groups, whereas only 60 % was observed for control group. 
Lactic acid bacteria (LAB) count of intestine digesta of fish that survived was 
maintained at high count (> 6 log cfu/ml) compared to control. On the other hand, the 
Enterobacteriaceae and A. hydrophila count were maintained at low count (< 6 log 
cfu/ml) after the trial. For the second trial, tilapia was orally immunized using 
recombinant L. lactis for four weeks. The growth performance of fish with 
recombinant L. lactis was more profound than control fish, even after challenged 
with A. hydrophila. Moreover, the antibody level increased significantly in week 2 in 
fish serum fed with recombinant L. lactis compared to control. The survival rate of 
tilapia after challenge was 100 % for recombinant L. lactis. The Enterobacteriaceae 
and A. hydrophila count of intestine digesta of survived fish was maintained at low 
count (< 5 log cfu/ml) compared to control, whereas the LAB count were maintained 
at more than 4 log cfu/ml.  
 
The best bacteriocin producer from six strains of L. plantarum isolated from local 
foods was identified and bacteriocin UL4 was selected based on antimicrobial 
activity determined by the diameter of the inhibition zone of A. hydrophila. Oral 
feeding was carried out and better growth performance was observed in bacteriocin 
UL4 fed tilapia compared to control. ELISA results showed the antibody level 
increased significantly in week 3 in fish serum fed with bacteriocin compared to 
 iii
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control. The survival rate after challenge was 100 % and only 45 % for bacteriocin 
fed fish and control fish respectively. Enterobacteriaceae and A. hydrophila count of 
intestine digesta of survived fish maintained at low count (< 5 log cfu/ml) compared 
to control, whereas LAB count were maintained at high count (> 6 log cfu/ml). 
 
The results obtained in this study indicate the vast potential of recombinant L. lactis 
as a promising vaccine to prevent the infection of A. hydrophila particularly and 
generally to reduce the extensive use of antibiotics in controlling diseases and for the 
overall improvement of the health of fishes. The bacteriocin from LAB also showed 
good effects on the health improvement of fish and could be an ideal alternative to be 
used as a supplement for a general protection and prevention of diseases. 
Abstrak tesis yang dikemukan kepada Senat Universiti Putra Malaysia sebagai 
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Kajian ini dijalankan untuk menentukan kesan rekombinan Lactococcus lactis dan 
bakteriosin UL4 untuk perlindungan ikan tilapia terhadap Aeromonas hydrophila. 
Dalam kajian ini, 250 bp domain 1 dan 750 bp domain 4 aerolysin telah diamplifikasi 
dengan PCR dan diklon dalam pNZ8048 secara berasingan. Plasmid yang telah 
dihasilkan, iaitu pNHD1 dan pNHD4 dielektrotransformasikan ke dalam 
Lactococcus lactis. Selepas itu, RNA diekstrak dan digunakan untuk transkrip 
terbalik PCR dan keputusan gel agaros menunjukkan jalur pada saiz yang dijangka 
bagi pNHD1 dan pNHD4 dengan 268 bp dan 768 bp masing-masing. Sejurus itu, 
protein sel rekombinan L. lactis diekstrak dan dipisahkan menggunakan SDS-PAGE 
sebelum kajian Western Blot dilakukan. Western Blot dengan mengunakan spesifik 
antibodi poliklonal menunjukkan kedua-dua domain 1 (~ 9 kDa) dan 4 (~30 kDa) 
telah berjaya diekspres dalam L. lactis.  
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Bagi experimen yang pertama, ikan tilapia telah disuntik secara intraperitoneal 
dengan mengunakan rekombinan bakteria L. lactis. Kadar pertumbuhan tilapia 
dengan mengunakan rekombinan L. lactis lebih tinggi dan keputusan ELISA 
menunjukkan tahap antibodi meningkat dengan signifikan (P<0.05) bagi rekombinan 
L. lactis. Kadar hidup tilapia selepas dicabar, adalah melebihi 80 % bagi kumpulan 
rekombinan L. lactis, manakala hanya 60 % untuk rawatan kawalan. Kiraan LAB 
dalam digesta ikan dikekalkan pada tahap tinggi (> 6 log cfu/ml) berbanding rawatan 
kawalan dan kiraan Enterobacteriaceae dan A. hydrophila dikekalkan pada tahap 
rendah (< 6 log cfu/ml). Bagi eksperimen kedua, ikan tilapia diberi vaksin secara oral 
untuk 4 minggu. Kadar pertumbuhan tilapia dengan mengunakan rekombinan L. 
lactis lebih tinggi daripada rawatan kawalan, walaupun selepas dicabar dengan A. 
hydrophila. Keputusan ELISA menunjukkan tahap antibodi meningkat dengan 
signifikan (P<0.05) bagi rekombinan L. lactis pada minggu kedua berbanding dengan 
rawatan kawalan. Kadar hidup selepas dicabar dengan A. hydrophila adalah 100 % 
bagi rekombinan L. lactis. Kiraan Enterobacteriaceae dan A. hydrophila dalam usus 
ikan dikekalkan pada tahap rendah (< 5 log cfu/ml) berbanding kontrol. Manakala, 
kiraan LAB dikekalkan pada tahap tinggi (> 4 log cfu/ml). 
 
Bakteriosin yang terbaik daripada enam strain Lactobacillus plantarum di kenalpasti 
dan bakteriosin UL4, dipilih berdasarkan aktiviti bakteriosin dan diameter zon 
perencatan dengan A. hyrophila. Pemakanan oral diberikan dengan mengunakan 
bakteriosin dan kadar pertumbuhan tilapia dengan mengunakan bakteriosin lebih 
tinggi daripada kawalan, walaupun selepas dicabar dengan A. hydrophila. Keputusan 
ELISA menunjukkan tahap antibodi meningkat dengan signifikan (P<0.05) bagi 
bakteriosin pada minggu ketiga berbanding dengan rawatan kawalan. Kadar hidup 
 vi
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tilapia selepas dicabar dengan A. hydrophila adalah 100 % bagi bakteriosin manakala 
hanya 45 % bagi kawalan. Kiraan Enterobacteriaceae dan A. hydrophila dalam 
digesta ikan dikekalkan pada tahap rendah (< 5 log cfu/ml) dan kiraan LAB 
dikekalkan pada tahap tinggi (> 6 log cfu/ml) berbanding kawalan. 
 
Keputusan yang diperolehi menunjukan potensi rekombinan L. lactis sebagai vaksin 
bagi mencegah jangkitan daripada A. hydrophila khususnya dan juga mengurangkan 
pengunaan antibiotik bagi mengawal penyakit. Manakala, bakteriosin dari LAB 
menunjukan kesan yang baik bagi memperbaiki kesihatan ikan dan boleh menjadi 
alternatif sebagai makanan tambahan untuk mencegah jangkitan secara umum. 
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Lactic acid bacteria (LAB) are Gram positive and nonspore forming cocci or rods, 
which produce lactic acid as their main metabolic product. The genera Lactobacillus, 
Lactococcus, Leuconostoc, Pediococcus and Streptococcus are important members 
of this group. LAB are commonly found in foods, including fermented meat, 
vegetables, fruits, beverages and dairy products, but also in the respiratory, intestinal 
and genital tracts of humans and animals, in sewage and in plant materials (de Vuyst 
and Vandamme, 1994). The importance of LAB is increasing due to its classification 
as “generally regarded as safe” organism (GRAS) (Gatesoupe, 1999). 
 
LAB and their biotechnological exploitations have received vast attention for the last 
two decades. One significant example is the application of protein engineering 
techniques in LAB, notable examples being the lactococcal proteinase (Vos et al., 
1990), the lactose repressor gene of Lactococcus lactis (van Rooijen et al., 1993) and 
the lantibiotic nisin (Kuipers et al, 1992). Bacteriocins in general have been 
characterized in considerable detail, for instances the additional lantibiotics such as 
lactocin S from Lactobacillus sake (Nes et al., 1993) and the emergence of a group 
of related 'small heat stable bacteriocins' which  produces by several species of LAB 
(Marugg et al., 1992). Bacteriocins can be used as a ‘target drugs’ towards specific 
pathogens without disturbing the beneficial microbiota. Hence, they could then limit 
the use of antibiotics to some extent and thus delay the evolution of antibiotic 
resistance. Bacteriocins are naturally produced, so they are more easily accepted by 
consumers. Interest in bacteriocins is to some extent fuelled by their potential as 
novel biopreservatives and several have been shown vast potential in this regard. 
 
LAB that use as live organisms in food fermentations may be the suitable 
microoganisms for live vaccine delivery vectors. For example, L. lactis is a food-
grade, non-pathogenic, non-invasive and non-colonizing bacterium that has the 
potential to deliver vaccine antigen effectively (van Rooijen et al., 1993).  Recently, 
recombinant strains of L. lactis have been developed to deliver cytokines and specific 
antigens across mucosal surfaces to the immune system of animals (Nga, 2005). 
Protein secretion by this GRAS bacterium would allow production directly in a food 
product and interaction between the secreted protein (enzyme or antigen) and the 
environment (the food product itself or the digestive tract). High level production of 
heterologous proteins in L. lactis has been obtained using lactococcal constitutive or 
inducible promoters (Kuipers et al., 1997; de Vos, 1999).  
 
To develop efficient vaccines, two components are essential: the bacterial vector 
strain and a well-adapted antigen presentation system. Ideal mucosal vaccines should 
promote an effective contact between the antigen and the immune system, stimulate 
humoral and cellular immune responses, produce long term protection after a single 
dose, stable and non-toxic (Jennings et al., 1998). To circumvent some of the safety 
and environmental issues inherent to the wide-scale dissemination of engineered 
pathogens, non-pathogenic Gram-positive LAB vectors have been developed 
(Ribeiro et al., 2002). In addition to their GRAS status, some LAB are able to 
stimulate the immune system of the hosts as adjuvants due to their probiotic 
properties and their immunomodulation capacity (Shu and Gill, 2002). The 
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combinations of these properties makes LAB to be very advantageous live vaccines 
and many studies are under way to express antigens in LAB and to evaluate the 
effect of this antigen presentation system on the immune system. 
 
The research of LAB for aquatic animals is increasing with the demand for evolution 
of aquaculture approach to “environment-friendly” or “Green agriculture”. 
Aquaculture plays an important role in global food supply, food security and the 
development of national economies. In Malaysia, fish production is expected to 
increase from 1.48 million metric tonnes in 2000 to 1.93 million metric tonnes by 
2010 (Liaw and Fung, 2000). The fact that national marine capture fisheries already 
have an upper limit of production. It means that the demand must be met by the 
aquaculture industry. The main drawbacks identified in aquaculture industry are the 
nutrition and disease problems, which are the main problems of the unsatisfactorily 
production of aquaculture. 
 
Specific bacterial pathogens can be an important cause of mortalities in fish 
hatcheries, as intensive husbandry practice often result in breakdown of the natural 
host barriers. One of the difficulties of intensive fish culture is the control of diseases 
caused by pathogens such as Aeromonas hydrophila, one of the most common 
bacteria in freshwater. Possible consequences of A. hydrophila infection to fish are 
skin lesions, which can result in haemorrhagic septicaemia and followed by high 
mortalities (Rahman and Kawai, 1999). However, the indiscriminate use of 
antibiotics in disease control in many sections of the aquaculture industry has led to 
selective pressure of antibiotic resistance in bacteria, a property that may be readily 
transferred to other bacteria (Sorum, 1999). It also poses a significant risk to 
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consumer's health through the potential transfer of resistance to human pathogens, 
antibiotic residues or chemical contaminants in marketed aquaculture products. 
Further, widespread use of antibiotics also places the production environment at risk 
(Sahoo and Mukherjee, 1999). Hence, the use of live microbial feed supplement 
which benefit the host by modifying the host-associated or ambient microbial 
community, by enhancing the host response towards disease, by ensuring improved 
use of feed or enhancing its nutritional value or by improving the quality of its 
ambient environment (Vershuere et al., 2000) in aquaculture is being encouraged. 
 
 The exact mode of action of the probiotic bacteria has not been fully elucidated, 
nevertheless it is thought to be mediated through the production of inhibitory 
compounds, competition for chemicals or available energy or for adhesion sites 
besides enhancing immune responses. Very little is known about the relative 
importance of these mechanisms. In addition, only Villamil et al., (2002) and 
Rengpipat et al., (2000) reported the immune responses in aquatic animals after 
probiotic supplementation. On the other hand, during the last decade the application 
of probiotics taking advantage of its pathogen control potential has been increasing 
in aquaculture. According to Gudding et al., (1999), stimulation of the specific and 
non-specific immunity is the basis for developing aquaculture into sustainable       
bioproduction in aquatic ecosystems. 
 
A need to overcome this problem has arisen and possible solutions can be found by 
using LAB as feed supplement or as vaccine delivery vehicle.  Although the 
promising prospects of LAB have been extensively reported, but considerable 
research on recombinant LAB carrying specific antigen epitopes of pathogen as live 
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vaccines and the potential of LAB metabolites on aquaculture have not been 
conducted. Therefore, this study was conducted to investigate the use of recombinant 
Lactococcus lactis and bacteriocin UL4 for the protection of tilapia, Oreochromis 
niloticus, against Aeromonas hydrophila and the specific objectives of this study 
were: 
 
i) To construct recombinant L. lactis harboring aerolysin domains 1 and 4 of 
A. hydrophila. 
 
ii) To determine the efficacy of L. lactis recombinants harbouring the 
constructs of aerolysin domains 1 and 4 of A. hydrophila as vaccine for 
tilapia via intraperitoneal injection. 
 
 
iii) To determine the efficacy of L. lactis recombinants harbouring the 
constructs of aerolysin domains 1 and 4 of A. hydrophila as oral vaccine 
for tilapia. 
 











2.1  Aeromonads 
Aeromonads are ubiquitous, oxidase-positive, facultatively anaerobic, glucose-
fermenting, Gram-negative bacteria that are native to aquatic environments (Hazen et 
al., 1978). They have been found in brackish, fresh, estuarine, marine, chlorinated 
and unchlorinated water supplies worldwide, with the highest numbers obtained in 
the warmer months (Van der Kooj et al., 1988; Kaper et al., 1981 and Hazen et al., 
1978). Aeromonads have been isolated from diseased cold and warm blooded 
animals for over 100 years and from humans since the early 1950s (Mathewson and 
Dupont, 1992).   
 
The motile aeromonads, as the group appellation suggests, are characterized by 
active motility, achieved by means of a single polar flagellum, and production of gas, 
as well as acid from carbohydrates. They are bacilli or cocci-bacilli measuring       
0.5 µm × 1.0 - 1.5 µm. The optimum growth temperature for motile aeromonads is 
28 °C but depending upon the species, it varies with a very wide temperature growth 
range (< 4 °C to 45 °C) and optimal pH value around 6.5 - 7.5 with a range of 5.2 to 
9.8 pH tolerability (Anjana et  al., 2005).  
 
The genus Aeromonas has undergone a number of taxonomic and nomenclature 
revisions (Chacon et al., 2002). Although originally placed in the family which also 
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